{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:13:23Z","timestamp":1791645203813,"version":"4.3.4"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00797","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T04:37:57Z","timestamp":1598330277000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders"],"prefix":"10.3389","volume":"11","author":[{"given":"Paul","family":"Enck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Klosterhalfen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2005.00676.x","article-title":"The placebo response in functional bowel disorders: perspectives and putative mechanisms","volume":"17","author":"Enck","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i25.3425","article-title":"Placebo responses in patients with gastrointestinal disorders","volume":"13","author":"Musial","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.117","article-title":"Placebo effects and their determinants in gastrointestinal disorders","volume":"12","author":"Elsenbruch","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.10.003","article-title":"Novel designs and paradigms to study the placebo response in gastroenterology","volume":"37","author":"Enck","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00626-3","article-title":"Defining the predictors of the placebo response in irritable bowel syndrome","volume":"3","author":"Pitz","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2005.00650.x","article-title":"The placebo effect in irritable bowel syndrome trials: a meta-analysis","volume":"17","author":"Patel","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2007.00937.x","article-title":"A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome","volume":"19","author":"Dorn","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90319-8","article-title":"Controlled treatment trials in the irritable bowel syndrome: a critique","volume":"95","author":"Klein","year":"1988","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00086-8","article-title":"Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials","volume":"107","author":"Spiller","year":"1999","journal-title":"Am J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.irn.2018.07.018","article-title":"Knowledge Gaps in Placebo Research: With Special Reference to Neurobiology","volume":"139","author":"Enck","year":"2018","journal-title":"Int Rev Neurobiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00565-9","article-title":"The digital placebo effect: mobile mental health meets clinical psychiatry","volume":"3","author":"Torous","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/164_2019_269","article-title":"Placebos and the Placebo Effect in Drug Trials","volume":"260","author":"Enck","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1159\/000490354","article-title":"Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus","volume":"87","author":"Evers","year":"2018","journal-title":"Psychother Psychosom"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04328.x","article-title":"Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome","volume":"32","author":"Ford","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1038\/tp.2015.143","article-title":"Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis","volume":"5","author":"Masi","year":"2015","journal-title":"Transl Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665117002816","article-title":"The challenges of control groups, placebos and blinding in clinical trials of dietary interventions","volume":"76","author":"Staudacher","year":"2017","journal-title":"Proc Nutr Soc"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.03.011","article-title":"The road to rome","volume":"130","author":"Thompson","year":"2006","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30509.x","article-title":"Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome","volume":"99","author":"Chey","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-44519-8_14","article-title":"Traditional and innovative experimental and clinical trial designs and their advantages and pitfalls","volume":"225","author":"Weimer","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/003655201750305440","article-title":"Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies","volume":"36","author":"Allescher","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00781.x","article-title":"Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses","volume":"94","author":"Mearin","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MEG.0b013e32834bb951","article-title":"Placebo responses and placebo effects in functional bowel disorders","volume":"24","author":"Enck","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-014-0974-7","article-title":"The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders","volume":"49","author":"Savarino","year":"2014","journal-title":"J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0258-6","article-title":"Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-analysis of Randomized Control Trials","volume":"114","author":"Pittayanon","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000365248","article-title":"Age and sex as moderators of the placebo response - an evaluation of systematic reviews and meta-analyses across medicine","volume":"61","author":"Weimer","year":"2015","journal-title":"Gerontology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04374.x","article-title":"Systematic review: self-management support interventions for irritable bowel syndrome","volume":"32","author":"Dorn","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178676","article-title":"Quantification of the placebo response in ulcerative colitis","volume":"112","author":"Ilnyckyj","year":"1997","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.024","article-title":"A meta-analysis of the placebo rates of remission and response in clinical trials of active crohn\u2019s disease","volume":"126","author":"Su","year":"2004","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw004","article-title":"Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis","volume":"10","author":"Jairath","year":"2016","journal-title":"J Crohns Colitis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13973","article-title":"Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn\u2019s disease","volume":"45","author":"Jairath","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy100","article-title":"Placebo effect on the health-related quality of life of inflammatory bowel disease patients: a systematic review with meta-analysis","volume":"12","author":"Estevinho","year":"2018","journal-title":"J Crohns Colitis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14672","article-title":"Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis","volume":"47","author":"Ma","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy365","article-title":"Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis","volume":"25","author":"Macaluso","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.08.025","article-title":"Response to Placebo, Measured by Endoscopic Evaluation of Crohn\u2019s Disease Activity, in a Pooled Analysis of Data from 5 Randomized Controlled Induction Trials","volume":"18","author":"Duijvestein","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00094.x","article-title":"Placebo effect in the treatment of duodenal ulcer","volume":"48","author":"de Craen","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2036.2010.04315.x","article-title":"Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease","volume":"32","author":"Cremonini","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-9-1","article-title":"Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention","volume":"9","author":"Krogsboll","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jpsychires.2012.02.008","article-title":"Contribution of spontaneous improvement to placebo response in depression: a meta-analytic review","volume":"46","author":"Rutherford","year":"2012","journal-title":"J Psychiatr Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2019-111161","article-title":"Is there a genuine placebo effect in acute depression treatments? A reassessment of regression to the mean and spontaneous remission","volume":"25","author":"Hengartner","year":"2020","journal-title":"BMJ Evid Based Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.07.066","article-title":"Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn\u2019s disease","volume":"135","author":"Renna","year":"2008","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2036.2009.04038.x","article-title":"Meta-analysis: incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo-controlled NSAID trials","volume":"30","author":"Yuan","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.8342","article-title":"Placebo Competence Team,. Avoiding nocebo effects to optimize treatment outcome","volume":"312","author":"Bingel","year":"2014","journal-title":"JAMA"},{"key":"B43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1124\/pr.114.009423","article-title":"Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice","volume":"67","author":"Schedlowski","year":"2015","journal-title":"Pharmacol Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1046\/j.1468-2982.1999.019008699.x","article-title":"Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials","volume":"19","author":"Diener","year":"1999","journal-title":"Cephalalgia"},{"key":"B45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejpain.2007.03.002","article-title":"Placebo response in the prophylaxis of migraine: a meta-analysis","volume":"12","author":"Macedo","year":"2008","journal-title":"Eur J Pain"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0088-5","article-title":"A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials","volume":"62","author":"Macedo","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01788.x","article-title":"Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults","volume":"29","author":"Ho","year":"2009","journal-title":"Cephalalgia"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.10391","article-title":"Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis","volume":"173","author":"Meissner","year":"2013","journal-title":"JAMA Intern Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.06.024","article-title":"Placebo response in neuropathic pain trials","volume":"138","author":"Quessy","year":"2008","journal-title":"Pain"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.092015","article-title":"The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials","volume":"67","author":"Zhang","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.01.050","article-title":"Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors","volume":"152","author":"Hauser","year":"2011","journal-title":"Pain"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e318249ce93","article-title":"Meta-analysis: the placebo rate of abdominal pain remission in clinical trials of chronic pancreatitis","volume":"41","author":"Capurso","year":"2012","journal-title":"Pancreas"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3595-8","article-title":"The placebo effect and its determinants in fibromyalgia: meta-analysis of randomised controlled trials","volume":"36","author":"Chen","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-018-5199-9","article-title":"Placebo Rates in Randomized Controlled Trials of Pouchitis Therapy","volume":"63","author":"Athayde","year":"2018","journal-title":"Dig Dis Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13075-019-1951-6","article-title":"Meta-analysis of pain and function placebo responses in pharmacological osteoarthritis trials","volume":"21","author":"Huang","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/joor.12827","article-title":"Placebo and nocebo response magnitude on temporomandibular disorders related-pain: a systematic review and meta-analysis","volume":"46","author":"Porporatti","year":"2019","journal-title":"J Oral Rehabil"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.9.1403","article-title":"Characteristics of placebo responses in medical treatment of premenstrual syndrome","volume":"156","author":"Freeman","year":"1999","journal-title":"Am J Psychiatry"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000156969.76986.e0","article-title":"The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis","volume":"67","author":"Cho","year":"2005","journal-title":"Psychosom Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2288-9-55","article-title":"A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder","volume":"9","author":"Lee","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"B60","first-page":"8","article-title":"Factors contributing to failed trials of new agents: can technology prevent some problems","volume":"63","author":"Greist","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/JCP.0b013e31802eb4b7","article-title":"Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms","volume":"27","author":"Kobak","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1159\/000209348","article-title":"Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials","volume":"78","author":"Rutherford","year":"2009","journal-title":"Psychother Psychosom"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(14)00092-3","article-title":"Placebo effects in psychiatry: mediators and moderators","volume":"2","author":"Weimer","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cgh.2018.04.009","article-title":"Factors associated with response to placebo in patients with irritable bowel syndrome and constipation","volume":"16","author":"Ballou","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00407","article-title":"Placebo Effect in the Treatment of Depression and Anxiety","volume":"10","author":"Kirsch","year":"2019","journal-title":"Front Psychiatry"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.201","article-title":"Severity in irritable bowel syndrome: a Rome Foundation Working Team report","volume":"106","author":"Drossman","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2008.01241.x","article-title":"The placebo response in functional dyspepsia\u2013reanalysis of trial data","volume":"21","author":"Enck","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02845.x","article-title":"Predictors of the placebo response in functional dyspepsia","volume":"23","author":"Talley","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2014.06.012","article-title":"Are all placebo respondents non-smokers","volume":"83","author":"Enck","year":"2014","journal-title":"Med Hypotheses"},{"key":"B70","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/pr.2013.66","article-title":"Placebo effects in children: a review","volume":"74","author":"Weimer","year":"2013","journal-title":"Pediatr Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00160","article-title":"Does Sex\/Gender Play a Role in Placebo and Nocebo Effects? Conflicting Evidence From Clinical Trials and Experimental Studies","volume":"13","author":"Enck","year":"2019","journal-title":"Front Neurosci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2014.01079","article-title":"Prediction of placebo responses: a systematic review of the literature","volume":"5","author":"Horing","year":"2014","journal-title":"Front Psychol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2011.04.004","article-title":"Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact","volume":"50","author":"Rutherford","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30308-X","article-title":"Placebo response in depression: is it rising","volume":"3","author":"Enck","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20421","article-title":"Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013","volume":"16","author":"Khan","year":"2017","journal-title":"World Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/eb-2017-102827","article-title":"Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy","volume":"21","author":"Furukawa","year":"2018","journal-title":"Evid Based Ment Health"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0237","article-title":"Factors affecting therapeutic placebo response rates in patients with irritable bowel syndrome","volume":"2","author":"Enck","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.255","article-title":"A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation","volume":"107","author":"Rao","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3923","article-title":"The placebo response in medicine: minimize, maximize or personalize","volume":"12","author":"Enck","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.204","article-title":"Mechanisms involved in placebo and nocebo responses and implications for drug trials","volume":"90","author":"Rief","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1066","article-title":"Rethinking pragmatic randomised controlled trials: introducing the \u201ccohort multiple randomised controlled trial\u201d design","volume":"340","author":"Relton","year":"2010","journal-title":"BMJ"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197905313002203","article-title":"A new design for randomized clinical trials","volume":"300","author":"Zelen","year":"1979","journal-title":"N Engl J Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1353\/pbm.2018.0045","article-title":"Open-Label Placebo: Reflections on a Research Agenda","volume":"61","author":"Kaptchuk","year":"2018","journal-title":"Perspect Biol Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031339","article-title":"Effects of a probiotic treatment (Enterococcus faecalis) and open-label placebo on symptoms of allergic rhinitis: study protocol for a randomised controlled trial","volume":"9","author":"Schaefer","year":"2019","journal-title":"BMJ Open"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00797\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T04:38:01Z","timestamp":1598330281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00797\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":85,"alternative-id":["10.3389\/fpsyt.2020.00797"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00797","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"article-number":"797"}}